药物基因组学: 预测药物是否有效

介绍 | 益处 | 解释 | 问题与关注 | 展望 | 相关页面

文章来源

NOTE: 本文是根据利用以下参考文献所做的研究成果和“医学检验项目在线”编辑审核委员会全体成员的经验的基础上总结而成。本文由编辑委员会定期审核、更新。任何新引用的文献都会添加到列表中，并且会与原有的参考文献区分开。

Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Cattaneo, D. et. al. (2004 March 2). From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy. Medscape from Am J Transplant 4(3):299-310, 2004 [On-line journal]. Available online at http://www.medscape.com/viewarticle/470038 through http://www.medscape.com.

(2006 February 27, Modified). Pharmacogenomics. Human Genome Project Information [On-line information]. Available online at http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml through target="_blank>http://www.ornl.gov.

Ma, M. et. al. (2002 December 2). Genetic Basis of Drug Metabolism. Medscape from Am J Health-Syst Pharm 59(21):2061-2069, 2002 [On-line journal]. Available online at http://www.medscape.com/viewarticle/444804 through http://www.medscape.com.

Pharmacogenomics: A Clinician’s Primer on Emerging Technologies for Improved Patient Care. Mayo Communiqué [On-line information]. Available online at http://www.mayoreferenceservices.org/media-comm/apr2002.pdf#search='pharmacogenomics' through http://www.mayoreferenceservices.org.

Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part one. PriceWaterhouseCoopers [On-line information]. Available online at http://www.pwc.com/extweb/execpers.nsf/docid/1FABC5BA1F9A885F85257088006230C1 through http://www.pwc.com.

Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part two. PriceWaterhouseCoopers [On-line information]. Available online at http://www.pwc.com/extweb/execpers.nsf/docid/E918DAA0105A2939852570E00079022E through http://www.pwc.com.

(2003 November 3). FDA Issues Guidance on Pharmacogenomics Data. FDA News [On-line information]. Available online at http://www.fda.gov/bbs/topics/NEWS/2003/NEW00969.html through http://www.fda.gov.

Vega, C. (2004). The AAFP Focuses on Genomics. Highlights of the American Academy of Family Physicians 2004 Scientific Assembly and the 17th World Conference of Family Doctors [On-line CME/CE]. Available online at http://www.medscape.com/viewarticle/495064 through http://www.medscape.com.

Henry, C. and Washington, C&EN (2001 August 13). PHARMACOGENOMICS, Genetic markers such as single-nucleotide polymorphisms may lead to personalized medicines for a wide variety of diseases. Chemical and Engineering News v79 (33) pp 37-42. [On-line journal]. Available online at http://pubs.acs.org/cen/coverstory/7933/7933pharmacogenomics.html through http://pubs.acs.org.

Rauscher, M. (2006). Some People May be Genetically Susceptible to Chronic Fatigue. Reuters Health Information [On-line information]. Available online at http://www.medscape.com/viewarticle/530400_print through http://www.medscape.com.

Hayney, M. (2002 October 9). Pharmacogenomics and Infectious Diseases: Impact on Drug Response and Applications to Disease Management. Medscape from American Journal of Health-System Pharmacy 59(17): 1626-1631 [On-line journal]. Available online at http://www.medscape.com/viewarticle/442071 through http://www.medscape.com.

Norton, R. (2001). Pharmacogenomics and Individualized Drug Therapy. Medscape Pharmacotherapy 3(1), 2001. [On-line information]. Available online at http://www.medscape.com/viewarticle/408606 through http://www.medscape.com.

Khoury, M. and Morris, J. (2006 May 8, Updated). Pharmacogenomics & Public Health: The Promise of Targeted Disease Prevention. CDC, Genomics and Disease Prevention [On-line information]. Available online at http://www.cdc.gov/genomics/training/perspectives/factshts/pharmacofs.htm through http://www.cdc.gov.

Barash, C. (2001). Ethical, Legal, and Social Implications of Genomic Research. Medscape Pharmacotherapy 3(1), 2001 [On-line information]. Available online at http://www.medscape.com/viewarticle/408601 through http://www.medscape.com.

Ross, J. and Ginsburg, G. (2003 February 14). The Integration of Molecular Diagnostics With Therapeutics. Am J Clin Pathol 119(1):26-36, 2003. [On-line information]. Available online at http://www.medscape.com/viewarticle/447846 through http://www.medscape.com.

(2004 May 30, Revised). Microarrays: Chipping Away At The Mysteries Of Science And Medicine. National Center for Biotechnology Information [On-line information]. Available online at http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html through http://www.ncbi.nlm.nih.gov.

Rados, C. (2005 November-December). Genomics and Medical Devices: A New Paradigm for Health Care. FDA Consumer magazine [On-line information]. Available online at http://www.fda.gov/fdac/features/2005/605_devices.html through http://www.fda.gov.

(2004 December 23). FDA Clears First of Kind Genetic Lab Test. FDA News [On-line information]. Available online at http://www.fda.gov/bbs/topics/news/2004/new01149.html through http://www.fda.gov.

(2006 February 9). Draft Guidance for Industry and FDA Staff - Pharmacogenetic Tests and Genetic Tests for Heritable Markers. FDA Center for Devices and Radiological Health [On-line Draft Guidance]. Available online at http://www.fda.gov/cdrh/oivd/guidance/1549.html through http://www.fda.gov.

(2005 August 22). FDA Clears Genetic Test That Advances Personalized Medicine. FDA OVID News Archive [On-line News Release]. Available online at http://www.fda.gov/cdrh/oivd/news.html#042706 through http://www.fda.gov.

Freuh, F. (2005 April 26). Personalized Medicine: What is it? How will it affect health care? 11th Annual FDA Science Forum [On-line presentation]. PDF available for download at http://www.fda.gov/cder/genomics/scienceForum2005.pdf through http://www.fda.gov.

Meadows, M. (2005 November December) Genomics and Personalized Medicine. FDA Consumer Magazine [On-line information]. Available online at http://www.fda.gov/fdac/features/2005/605_genomics.html through http://www.fda.gov.

M. J. Kim, S. M. Huang, F. W. Frueh, A. N. Rahman, Y. M. Choi, K. M. Robie Suh, G. Shashaty, R. Rieves, L. J. Lesko. CDER, FDA, Silver Spring, MD (2006). Risk Management of Warfarin Overanticoagulation: Role of Pharmacogenomic Information. Available online at http://www.cfsan.fda.gov/~frf/forum06/K-16.htm through http://www.cfsan.fda.gov.

M Wadelius, M Piromohamed, (2006). Pharmacogenetics of Warfarin: current status and future challenges. The Pharmacogenomics Journal, 1-13.

« 上一页